A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells

S. R. Warrier, N. Haridas, S. Balasubramanian, A. Jalisatgi, R. Bhonde, A. Dharmarajan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Mesenchymal stem cells (MSCs) derived from post-natal tissues offer a suitable source of MSCs for cellular therapy. Limitation of the use of MSCs for therapeutic purposes is attributed to the onset of senescence and slowing down of proliferation upon repeated passaging. Dhanwantram kashaya (DK), a synthetic herbal formulation, is widely used in Ayurvedic medicine as a growth stimulant in children and for nerve regeneration. In this study, we evaluated the effects of DK on the proliferation, viability and senescence of human Wharton jelly MSCs (WJMSCs) in vitro. Results: Using the MTT proliferation assay and live/dead trypan blue analysis, we found that DK increased proliferation of WJMSCS up to three folds when supplemented in the culture media. The BrdU cell proliferation assay showed a substantial increase in WJMSCs treated with DK. Notably, the β-galactosidase senescence assay revealed that drug treated WJMSCs at late passage still had intact and viable WJMSCs whereas the untreated cells exhibited profound senescence. Conclusion: These studies indicate that DK enhances the quality of WJMSCs by not only increasing the proliferation rate and decreasing their turnover time but also by delaying senescence. We have, thus, identified for the first time that a traditional Ayurvedic formulation, Dhanwantram kashaya, used as a growth enhancer, is able to improve the yield and quality of stem cells in vitro and could be an effective non-toxic supplement for culturing WJMSCs for clinical applications.

Original languageEnglish
Pages (from-to)283-290
Number of pages8
JournalCell Proliferation
Volume46
Issue number3
DOIs
Publication statusPublished - 06-2013

Fingerprint

Wharton Jelly
Stem Cells
Mesenchymal Stromal Cells
Ayurvedic Medicine
Galactosidases
Nerve Regeneration
Trypan Blue
Bromodeoxyuridine
Growth
Cell- and Tissue-Based Therapy
Culture Media
Dhanwantharam kashaya
Cell Proliferation
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Warrier, S. R., Haridas, N., Balasubramanian, S., Jalisatgi, A., Bhonde, R., & Dharmarajan, A. (2013). A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. Cell Proliferation, 46(3), 283-290. https://doi.org/10.1111/cpr.12026
Warrier, S. R. ; Haridas, N. ; Balasubramanian, S. ; Jalisatgi, A. ; Bhonde, R. ; Dharmarajan, A. / A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. In: Cell Proliferation. 2013 ; Vol. 46, No. 3. pp. 283-290.
@article{b6a37286e04f4b54be384eca28e5cca2,
title = "A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells",
abstract = "Objectives: Mesenchymal stem cells (MSCs) derived from post-natal tissues offer a suitable source of MSCs for cellular therapy. Limitation of the use of MSCs for therapeutic purposes is attributed to the onset of senescence and slowing down of proliferation upon repeated passaging. Dhanwantram kashaya (DK), a synthetic herbal formulation, is widely used in Ayurvedic medicine as a growth stimulant in children and for nerve regeneration. In this study, we evaluated the effects of DK on the proliferation, viability and senescence of human Wharton jelly MSCs (WJMSCs) in vitro. Results: Using the MTT proliferation assay and live/dead trypan blue analysis, we found that DK increased proliferation of WJMSCS up to three folds when supplemented in the culture media. The BrdU cell proliferation assay showed a substantial increase in WJMSCs treated with DK. Notably, the β-galactosidase senescence assay revealed that drug treated WJMSCs at late passage still had intact and viable WJMSCs whereas the untreated cells exhibited profound senescence. Conclusion: These studies indicate that DK enhances the quality of WJMSCs by not only increasing the proliferation rate and decreasing their turnover time but also by delaying senescence. We have, thus, identified for the first time that a traditional Ayurvedic formulation, Dhanwantram kashaya, used as a growth enhancer, is able to improve the yield and quality of stem cells in vitro and could be an effective non-toxic supplement for culturing WJMSCs for clinical applications.",
author = "Warrier, {S. R.} and N. Haridas and S. Balasubramanian and A. Jalisatgi and R. Bhonde and A. Dharmarajan",
year = "2013",
month = "6",
doi = "10.1111/cpr.12026",
language = "English",
volume = "46",
pages = "283--290",
journal = "Cell Proliferation",
issn = "0960-7722",
publisher = "Wiley-Blackwell",
number = "3",

}

Warrier, SR, Haridas, N, Balasubramanian, S, Jalisatgi, A, Bhonde, R & Dharmarajan, A 2013, 'A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells', Cell Proliferation, vol. 46, no. 3, pp. 283-290. https://doi.org/10.1111/cpr.12026

A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. / Warrier, S. R.; Haridas, N.; Balasubramanian, S.; Jalisatgi, A.; Bhonde, R.; Dharmarajan, A.

In: Cell Proliferation, Vol. 46, No. 3, 06.2013, p. 283-290.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells

AU - Warrier, S. R.

AU - Haridas, N.

AU - Balasubramanian, S.

AU - Jalisatgi, A.

AU - Bhonde, R.

AU - Dharmarajan, A.

PY - 2013/6

Y1 - 2013/6

N2 - Objectives: Mesenchymal stem cells (MSCs) derived from post-natal tissues offer a suitable source of MSCs for cellular therapy. Limitation of the use of MSCs for therapeutic purposes is attributed to the onset of senescence and slowing down of proliferation upon repeated passaging. Dhanwantram kashaya (DK), a synthetic herbal formulation, is widely used in Ayurvedic medicine as a growth stimulant in children and for nerve regeneration. In this study, we evaluated the effects of DK on the proliferation, viability and senescence of human Wharton jelly MSCs (WJMSCs) in vitro. Results: Using the MTT proliferation assay and live/dead trypan blue analysis, we found that DK increased proliferation of WJMSCS up to three folds when supplemented in the culture media. The BrdU cell proliferation assay showed a substantial increase in WJMSCs treated with DK. Notably, the β-galactosidase senescence assay revealed that drug treated WJMSCs at late passage still had intact and viable WJMSCs whereas the untreated cells exhibited profound senescence. Conclusion: These studies indicate that DK enhances the quality of WJMSCs by not only increasing the proliferation rate and decreasing their turnover time but also by delaying senescence. We have, thus, identified for the first time that a traditional Ayurvedic formulation, Dhanwantram kashaya, used as a growth enhancer, is able to improve the yield and quality of stem cells in vitro and could be an effective non-toxic supplement for culturing WJMSCs for clinical applications.

AB - Objectives: Mesenchymal stem cells (MSCs) derived from post-natal tissues offer a suitable source of MSCs for cellular therapy. Limitation of the use of MSCs for therapeutic purposes is attributed to the onset of senescence and slowing down of proliferation upon repeated passaging. Dhanwantram kashaya (DK), a synthetic herbal formulation, is widely used in Ayurvedic medicine as a growth stimulant in children and for nerve regeneration. In this study, we evaluated the effects of DK on the proliferation, viability and senescence of human Wharton jelly MSCs (WJMSCs) in vitro. Results: Using the MTT proliferation assay and live/dead trypan blue analysis, we found that DK increased proliferation of WJMSCS up to three folds when supplemented in the culture media. The BrdU cell proliferation assay showed a substantial increase in WJMSCs treated with DK. Notably, the β-galactosidase senescence assay revealed that drug treated WJMSCs at late passage still had intact and viable WJMSCs whereas the untreated cells exhibited profound senescence. Conclusion: These studies indicate that DK enhances the quality of WJMSCs by not only increasing the proliferation rate and decreasing their turnover time but also by delaying senescence. We have, thus, identified for the first time that a traditional Ayurvedic formulation, Dhanwantram kashaya, used as a growth enhancer, is able to improve the yield and quality of stem cells in vitro and could be an effective non-toxic supplement for culturing WJMSCs for clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=84878209679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878209679&partnerID=8YFLogxK

U2 - 10.1111/cpr.12026

DO - 10.1111/cpr.12026

M3 - Article

VL - 46

SP - 283

EP - 290

JO - Cell Proliferation

JF - Cell Proliferation

SN - 0960-7722

IS - 3

ER -

Warrier SR, Haridas N, Balasubramanian S, Jalisatgi A, Bhonde R, Dharmarajan A. A synthetic formulation, Dhanwantharam kashaya, delays senescence in stem cells. Cell Proliferation. 2013 Jun;46(3):283-290. https://doi.org/10.1111/cpr.12026